INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 26, 2019 11:35 ET
|
Schall Law
LOS ANGELES, Aug. 26, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc....
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 20, 2019 09:20 ET
|
Schall Law
LOS ANGELES, Aug. 20, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc....
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eagle Bancorp, Karyopharm, L Brands, and National General and Encourages Investors to Contact the Firm
August 18, 2019 19:30 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Eagle Bancorp, Inc. (NASDAQ:...
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 12, 2019 13:20 ET
|
Schall Law
LOS ANGELES, Aug. 12, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc....
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Netflix, EQT, Eagle Bancorp, and Karyopharm and Encourages Investors to Contact the Firm
August 11, 2019 21:12 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Netflix, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against EQT Corporation, Eagle Bancorp, Karyopharm, and L Brands, Encourages Investors to Contact the Firm
August 05, 2019 21:30 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of EQT Corporation, Eagle...
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 05, 2019 14:35 ET
|
Schall Law
LOS ANGELES, Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc....
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Karyopharm Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 29, 2019 09:43 ET
|
Schall Law
LOS ANGELES, July 29, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Karyopharm Therapeutics Inc....
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) and Encourages Karyopharm Investors to Contact the Firm
July 24, 2019 21:30 ET
|
Bragar Eagel & Squire
NEW YORK, July 24, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts...
Karyopharm Taps TransPerfect as eTMF and Functional TMF Provider
April 06, 2016 14:00 ET
|
TransPerfect
NEW YORK, April 06, 2016 (GLOBE NEWSWIRE) -- TransPerfect, a leading provider of global development and commercialization solutions to the life sciences industry, today announced that Karyopharm...